Get startedLog in
    Picture of Cumberland Pharmaceuticals logo

    CPIX — Cumberland Pharmaceuticals Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Cumberland Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-3.42-3.6-5.65-6.33-6.44
    Depreciation
    Deferred Taxes
    Non-Cash Items0.531-2.84-1.672.02-1.5
    Discontinued Operations
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital3.538.1810.44.631.29
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accrued Expenses
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Cash from Operating Activities5.426.348.456.09-0.612
    Capital Expenditures-2.11-0.354-2.07-0.453-0.18
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items0.356-0.147-11.60.3470.238
    Acquisition of Business
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-1.76-0.502-13.7-0.1060.058
    Financing Cash Flow Items-1.76-2.17-2.21-3.27-1.72
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-7.12-3.55-2.06-7.420.197
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-3.462.29-7.28-1.44-0.357